EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

68Ga-FAPI PET/CT in Challenging Thyroid Cancer Cases: Complementary Findings and Interpretive Pitfalls in a Seven-Patient Case Series

Marwah Abdulrahman, Soud Al-Qasem, Saad Ruzzeh, Maryam Muthanna, Noor Abdul Malek, Tasneem Alkahder, Nouraldeen Alzorgan, Diyaa Juaidi, Hussam Haddad, Akram Al-Ibraheem

International Journal of Molecular Sciences · 20.11.2026 · 27 (22) · 10466

DOI: 10.3390/ijms272210466 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.11.2026. Verfasst von Marwah Abdulrahman und 9 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gallium-68 fibroblast activation protein inhibitor (68Ga-FAPI) PET/CT targets cancer-associated fibroblasts and may provide complementary information in challenging thyroid cancer cases. We retrospectively evaluated seven patients with thyroid cancer who underwent 68Ga-FAPI-04 PET/CT between November 2023 and December 2025 for suspected recurrent or metastatic disease or further characterization of known disease. The cohort comprised three males and four females (median age, 39 years; range, 20–81 years) with follicular cell-derived or medullary thyroid carcinoma. Findings were compared descriptively with available anatomical imaging, radioiodine scintigraphy, 18F-FDG PET/CT, and 68Ga-DOTATATE PET/CT. Histopathology and clinical or imaging follow-up were used for lesion characterization where available. FAPI uptake varied substantially, ranging from low uptake in histologically confirmed metastatic follicular thyroid carcinoma (SUVmax 1.5) to intense uptake in a gluteal lesion (early/delayed SUVmax 17.7/32.6) that subsequently regressed metabolically, favoring an inflammatory process. FAPI provided additional lesion characterization in medullary thyroid carcinoma, although a newly identified parapharyngeal lesion remained unconfirmed, and the muscular focus was indeterminate. Discordance with FDG and DOTATATE findings was also observed. 68Ga-FAPI PET/CT may provide complementary information in selected thyroid cancer cases but requires cautious interpretation alongside other imaging, histopathology, and follow-up.

Zitieren

APA

Abdulrahman, M., Al-Qasem, S., Ruzzeh, S., Muthanna, M., Malek, N. A., Alkahder, T., Alzorgan, N., Juaidi, D., Haddad, H., & Al-Ibraheem, A. (2026). 68Ga-FAPI PET/CT in Challenging Thyroid Cancer Cases: Complementary Findings and Interpretive Pitfalls in a Seven-Patient Case Series. International Journal of Molecular Sciences, 27(22), 10466. https://doi.org/10.3390/ijms272210466

Vancouver

Abdulrahman M, Al-Qasem S, Ruzzeh S, Muthanna M, Malek NA, Alkahder T, et al. 68Ga-FAPI PET/CT in Challenging Thyroid Cancer Cases: Complementary Findings and Interpretive Pitfalls in a Seven-Patient Case Series. International Journal of Molecular Sciences. 2026;27(22):10466. doi:10.3390/ijms272210466

BibTeX
@article{Abdulrahman2026,
  author = {Abdulrahman, Marwah and Al-Qasem, Soud and Ruzzeh, Saad and Muthanna, Maryam and Malek, Noor Abdul and Alkahder, Tasneem and Alzorgan, Nouraldeen and Juaidi, Diyaa and Haddad, Hussam and Al-Ibraheem, Akram},
  title = {68Ga-FAPI PET/CT in Challenging Thyroid Cancer Cases: Complementary Findings and Interpretive Pitfalls in a Seven-Patient Case Series},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10466},
  doi = {10.3390/ijms272210466}
}
Kostenlos starten →